• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌患者姑息治疗的当前选择。

Current options for palliative treatment in patients with pancreatic cancer.

作者信息

Ridwelski K, Meyer F

机构信息

Division of Oncosurgery/Oncology, Department of Surgery, University Hospital, Otto von Guericke University, Magdeburg, Germany.

出版信息

Dig Dis. 2001;19(1):63-75. doi: 10.1159/000050655.

DOI:10.1159/000050655
PMID:11385253
Abstract

Palliative treatment is often the only remaining option in the management of pancreatic carcinoma, but its efficacy is poor due to low tumor sensitivity and inadequate treatment protocols. There are several options of palliative treatment with antitumor or supportive intention. Classical end points of palliative treatment are survival, tumor response, and quality of life. A decade ago, palliative chemotherapy consisted mainly of 5-fluorouracil as the standard agent in combination with either other agents and/or radiotherapy. Only the new antineoplastic drug gemcitabine, which was introduced simultaneously with the definition of novel end points of chemotherapy such as clinical benefit, allowed to achieve some progress. However, while gemcitabine monotherapy appeared to be superior to 5-fluorouracil and improved important parameters of quality of life, it could not provide a significant improvement of survival. A novel concept, therefore, is to improve this beneficial cytostatic response in pancreatic carcinoma using a gemcitabine-based protocol by combining it with antineoplastic drugs such as taxanes or platin analogs. This strategy may have the potential to improve the outcome in palliative chemotherapy of pancreatic carcinoma patients with advanced tumor growth or metastases. Best supportive care in pancreatic cancer consists of the treatment of symptoms, such as pain, jaundice, duodenal obstruction, weight loss, exocrine pancreatic insufficiency, and tumor-associated depression.

摘要

姑息治疗往往是胰腺癌治疗中仅存的选择,但由于肿瘤敏感性低和治疗方案不完善,其疗效不佳。有几种具有抗肿瘤或支持意图的姑息治疗选择。姑息治疗的经典终点是生存期、肿瘤反应和生活质量。十年前,姑息化疗主要是以5-氟尿嘧啶作为标准药物,与其他药物和/或放疗联合使用。只有新型抗肿瘤药物吉西他滨,在诸如临床获益等化疗新终点定义的同时被引入,才使得取得了一些进展。然而,虽然吉西他滨单药治疗似乎优于5-氟尿嘧啶并改善了生活质量的重要参数,但它并不能显著提高生存期。因此,一个新的概念是通过将基于吉西他滨的方案与紫杉烷类或铂类类似物等抗肿瘤药物联合使用,来改善胰腺癌这种有益的细胞毒性反应。这种策略可能有潜力改善晚期肿瘤生长或转移的胰腺癌患者姑息化疗的结局。胰腺癌的最佳支持治疗包括对症状的治疗,如疼痛、黄疸、十二指肠梗阻、体重减轻、胰腺外分泌功能不全以及肿瘤相关性抑郁。

相似文献

1
Current options for palliative treatment in patients with pancreatic cancer.胰腺癌患者姑息治疗的当前选择。
Dig Dis. 2001;19(1):63-75. doi: 10.1159/000050655.
2
[How I treat ... An advanced pancreatic cancer].
Rev Med Liege. 2002 Mar;57(3):131-4.
3
[Contribution of gemcitabine in the treatment of advanced pancreatic cancer].[吉西他滨在晚期胰腺癌治疗中的作用]
Rev Med Interne. 1999 Sep;20(9):816-20. doi: 10.1016/s0248-8663(00)88691-9.
4
Gemcitabine: progress in the treatment of pancreatic cancer.吉西他滨:胰腺癌治疗的进展
Oncology. 2001;60(1):8-18. doi: 10.1159/000055290.
5
Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.吉西他滨耐药的晚期胰腺癌的治疗选择。
JOP. 2010 Mar 5;11(2):113-23.
6
Treatment of locally advanced pancreatic carcinoma in Sweden. A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care.
Pharmacoeconomics. 1999 Apr;15(4):377-84. doi: 10.2165/00019053-199915040-00005.
7
The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.吉西他滨单独及联合应用在胰腺癌治疗中的作用。
Anticancer Drugs. 2000 Nov;11(10):771-86. doi: 10.1097/00001813-200011000-00001.
8
Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.吉西他滨。对其在非小细胞肺癌和胰腺癌中的药理学及临床应用潜力的综述。
Drugs. 1997 Sep;54(3):447-72. doi: 10.2165/00003495-199754030-00009.
9
Gemcitabine in the treatment of metastatic pancreatic cancer.吉西他滨治疗转移性胰腺癌
Expert Rev Anticancer Ther. 2008 Apr;8(4):511-23. doi: 10.1586/14737140.8.4.511.
10
Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.胰腺癌:这片黯淡的前景终于要改变了吗?第43届美国临床肿瘤学会年会亮点。美国伊利诺伊州芝加哥。2007年6月1日至5日。
JOP. 2007 Jul 9;8(4):365-73.

引用本文的文献

1
Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.治疗胰腺外分泌功能不全对不可切除胰腺癌患者生存的影响:一项回顾性分析。
BMC Cancer. 2018 May 5;18(1):534. doi: 10.1186/s12885-018-4439-x.
2
[6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells.[6]-姜辣素诱导表达突变型p53的胰腺癌细胞发生细胞周期阻滞和细胞死亡。
Yonsei Med J. 2006 Oct 31;47(5):688-97. doi: 10.3349/ymj.2006.47.5.688.